Clean Vision Corp
Qualité des données : 100%
CLNV
OTC
Manufacturing
Chemicals
0,01 €
▲
0,00 €
(15,94%)
Cap. Boursière: 8,65 M
Prix
0,01 €
Cap. Boursière
8,65 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Negative free cash flow of -9,00 M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-10,25%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-4826,02%
Net Margin-5547,66%
Op. Margin-3321,93%
Sécurité
Debt / Equity
N/A
Current Ratio0,30
Interest Coverage-1,71
Valorisation
PE (TTM)
-0,63
Au-dessus de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -0,6 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,3 |
| Net Margin % | -5547,7 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10,25% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 248 295,0 | Net Income (TTM) | -13,77 M |
| ROE | N/A | ROA | -64,76% |
| Gross Margin | 92,16% | Operating Margin | -3321,93% |
| Net Margin | -5547,66% | Free Cash Flow (TTM) | -9,00 M |
| ROIC | -4826,02% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,30 |
| Interest Coverage | -1,71 | Asset Turnover | 0,01 |
| Working Capital | -14,93 M | Tangible Book Value | -20,61 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,63 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 34,82 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -104,06% | ||
| Market Cap | 8,65 M | Enterprise Value | 10,40 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,02 | Revenue / Share | 0,00 |
| FCF / Share | -0,01 | OCF / Share | -0,01 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 65,31% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 |
|---|---|---|
| Revenue | 231 040,0 | 257 414,0 |
| Net Income | -14,00 M | -12,29 M |
| EPS (Diluted) | -0,02 | — |
| Gross Profit | 219 609,0 | 162 789,0 |
| Operating Income | -7,31 M | — |
| EBITDA | — | — |
| R&D Expenses | 334 639,0 | 244 688,0 |
| SG&A Expenses | — | 1,07 M |
| D&A | 221 818,0 | 100 161,0 |
| Interest Expense | 5,55 M | 4,80 M |
| Income Tax | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 |
|---|---|---|
| Total Assets | 13,07 M | 10,59 M |
| Total Liabilities | 24,97 M | 12,56 M |
| Shareholders' Equity | -11,90 M | — |
| Total Debt | 1,75 M | 1,75 M |
| Cash & Equivalents | — | — |
| Current Assets | 3,42 M | 852 547,0 |
| Current Liabilities | 18,45 M | 10,81 M |
{"event":"ticker_viewed","properties":{"ticker":"CLNV","listing_kind":"stock","pathname":"/stocks/clnv","exchange":"OTC","country":"US"}}